Overview
Studies have shown that the first treatment you receive for cancer is by far the most important. On average, prostate cancer patients who begin their treatment at Seattle Cancer Care Alliance (SCCA) have better survival rates than those who started treatment elsewhere.
Prostate cancer can be a complex disease to treat. Our broad array of treatment options reflects our intensive and successful efforts to treat and cure patients with minimal side effects.
Our doctors specialize in prostate cancer and do not treat any other non-genitourinary cancers. Our team of medical oncologists, radiation oncologists, and surgeons works together to provide customized treatments for each patient.
Our patients receive state-of-the-art care, such as laparoscopic da Vinci robotic surgery, an effective, minimally invasive alternative to both open surgery and non-robotic laparoscopy. We also have the latest technology to provide the most precise radiation treatment possible, including brachytherapy and the Calypso System (also called GPS for the Body), special equipment to detect motion and position of the prostate during radiation treatment. Many new drugs or alternative treatments under investigation in clinical studies are available only at SCCA and selected sites around the country.
SCCA received a Specialized Program of Research Excellence (SPORE) grant for our prostate cancer science expertise and a Department of Defense (DOD) Clinical Trials Consortium grant for our clinical studies expertise. The SPORE grant was awarded to only 11 institutions around the country and the DOD grant to only 13 institutions. SCCA is one of only five institutions with both of these important research grants currently funded, a testament to our expertise and dedication to treating and curing prostate cancer.
Join Us On